Abstract
Rheumatoid Arthritis, a prevalent chronic inflammatory condition, imposes significant burdens on affected individuals globally. Kewra oil derived from Pandanus odoratissimus flowers, is reputed for its anti‐inflammatory properties in traditional medicine. This study aimed to assess the pharmacological effects of P. odoratissimus in an experimental rat model of arthritis along with an in‐silico study. An in‐silico study performed with PDB ID: 3GN8 and Dexamethasone was taken as standard reference. Thirty‐six male Wistar rats were randomized into six groups: normal control, arthritis control, standard (Dexamethasone‐ 1 mg/kg, s.c.), and three treatment groups receiving varied doses of extract P. odoratissimus (50, 100, and 200 mg/kg, oral). Arthritis was induced by injecting Freund's complete adjuvant into the rats' right hind paws. Treatment groups received oral P. odoratissimus extract once daily for 4 weeks. Paw volume, joint circumference, arthritis index, hematological parameters, inflammatory markers, and histopathological changes were assessed to check the arthritis severity. In Kewra oil, 56 bioactive were identified by gas chromatography‐mass spectrometry, and out of them, 54 molecules have dock score and dG binding value, which have more and less anti‐inflammatory effects. Out of 54 molecules, 30 molecules have good hydrogen bond interaction with different types of amino acids in receptors. The in‐vivo results state that rats when treated with P. odoratissimus, showed significant (p < 0.05) arthritis index, joint circumference, paw volume, improved weight‐bearing capacity, and inflammatory markers of rats treated with P. odoratissimus were significantly less than those in arthritis‐control rats (p < 0.05). The predicted anti‐inflammatory effects of the Kewra oil were validated by performing an in‐vivo study. P. odoratissimus holds potential as a natural remedy for arthritis, meriting continued exploration for therapeutic application.

This publication has 32 references indexed in Scilit: